Question to the Department for International Development:

To ask the Secretary of State for International Development, what steps her Department has taken to ensure that the Drugs for Neglected Diseases initiative provides for products that are affordable for patients.

DFID supports DNDi because its operational model puts the needs of patients at the heart of what it does and builds in equitable and affordable access to the end product from the outset. DNDi includes these approaches in its contractual relationships with industrial partners and by delinking the cost of the final product from the costs of research and development.